Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T29130 | Target Info | |||
Target Name | Signal transducer and activator of transcription 3 (STAT3) | ||||
Synonyms | Acute-phase response factor; APRF | ||||
Target Type | Successful Target | ||||
Gene Name | STAT3 | ||||
Biochemical Class | Transcription factor | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 2 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Biochemical Activity | [2] | |||
Interacting Protein Name | Nuclear receptor coactivator 1 (NCOA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | F.SRC.1; KAT13A; RIP160; SRC1; bHLHe42; bHLHe74 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Reconstituted Complex | [4] | |||
Kinases | [+] 9 Kinases | + | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [5] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Biochemical Activity | [7] | |||
4 | Co-localization | [8] | |||
5 | Protein-Fragment Complementation Assay | [5] | |||
6 | Yeast two hybrid | [9] | |||
Interacting Target Name | Janus kinase 2 (JAK-2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase JAK2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Biochemical Activity | [11] | |||
3 | Co-localization | [12] | |||
Interacting Target Name | Serine/threonine-protein kinase mTOR (mTOR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TOR kinase; Target of rapamycin; RAPT1; Rapamycin target protein 1; Rapamycin target protein; Rapamycin and FKBP12 target 1; RAFT1; Mechanistic target of rapamycin; Mammalian target of rapamycin; FRAP2; FRAP1; FRAP; FKBP-rapamycin associated protein; FKBP12-rapamycin complex-associated protein; FK506-binding protein 12-rapamycin complex-associated protein 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Biochemical Activity | [14] | |||
3 | Reconstituted Complex | [15] | |||
Interacting Target Name | Proto-oncogene c-Src (SRC) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase (pp60(src)); SRC1; Src tyrosine kinase; Proto-oncogene tyrosine-protein kinase Src; pp60c-src; Pp60(src); P60-Src; C-src TK; C-Src | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [16] | |||
2 | Co-localization | [17] | |||
3 | Reconstituted Complex | [16] | |||
Interacting Target Name | Erbb2 tyrosine kinase receptor (HER2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER2; Tyrosine kinase receptor ErbB2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; P185erbB2; NGL; NEU proto-oncogene; NEU; MLN19; MLN 19; Metastatic lymph node gene 19 protein; HER2/neu; HER2 (erbB2/neu); HER-2; Erb2; Epidermal growth factor receptor 2; C-erbB-2 oncoprotein; C-erbB-2; CD340 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [18] | |||
2 | Protein-peptide | [19] | |||
Interacting Target Name | Proto-oncogene c-Ret (RET) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RET51; RET receptor tyrosine kinase; RET mutant Y791F; RET mutant V804M; RET mutant V804L; RET mutant S891A; RET mutant M918T; RET mutant G691S; PTC; Proto-oncogene tyrosine-protein kinase receptor Ret; C-ret; CDHR16; CDHF12; Cadherin family member 12 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Co-localization | [20] | |||
Interacting Target Name | Janus kinase 1 (JAK-1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase JAK1; JAK1B; JAK1A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Reconstituted Complex | [22] | |||
Interacting Target Name | Focal adhesion kinase 1 (FAK) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; pp125FAK; p125FAK; FRNK; Focal adhesion kinase-related nonkinase; FAK1; FADK 1; FADK | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [23] | |||
2 | Co-localization | [20] | |||
Interacting Target Name | Tyrosine-protein kinase BMX (BMX) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NTK38; ETK; Epithelial and endothelial tyrosine kinase; Cytoplasmic tyrosine-protein kinase BMX; Bone marrow tyrosine kinase gene in chromosome X protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [24] | |||
2 | Yeast two hybrid | [25] | |||
Nuclear hormone receptors | [+] 2 Nuclear hormone receptors | + | |||
Interacting Target Name | Androgen receptor (AR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR; Androgen receptor | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [26] | |||
2 | Reconstituted Complex | [22] | |||
Interacting Target Name | Glucocorticoid receptor (NR3C1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear receptor subfamily 3 group C member 1; GRL; GR; Glucocorticoid receptor; Alpha-A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [27] | |||
2 | Reconstituted Complex | [28] | |||
Transcription regulators | [+] 5 Transcription regulators | + | |||
Interacting Target Name | Signal transducer and activator of transcription 1 (STAT1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor ISGF-3 components p91/p84; STAT-1; Signal transducers and activators of transcription factor; Signal transducer and activator of transcription 1-alpha/beta; P91 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [29] | |||
2 | Affinity Capture-Western | [30] | |||
3 | Co-localization | [20] | |||
4 | Reconstituted Complex | [31] | |||
Interacting Target Name | Nuclear factor NF-kappa-B (NFKB) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oncogene Lyt-10; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Nuclear factor NF-kappa-Bp52 subunit; Nuclear factor NF-kappa-B p100 subunit; Lyt10; Lymphocyte translocation chromosome 10 protein; Lymphocyte translocation chromosome 10; H2TF1; DNA-binding factor KBF2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [32] | |||
2 | Co-localization | [33] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Biochemical Activity | [2] | |||
Interacting Protein Name | Hypermethylated in cancer 1 protein (HIC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ZBTB29; ZNF901; hic.1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Reconstituted Complex | [35] | |||
Interacting Protein Name | Transcription factor p65 (RELA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFKB3; p65 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Reconstituted Complex | [36] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 1999 Apr 16;284(5413):479-82. | ||||
REF 2 | Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 2005 Jan 14;307(5707):269-73. | ||||
REF 3 | The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression. J Cell Biochem. 2007 Dec 1;102(5):1256-70. | ||||
REF 4 | Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem. 2002 Mar 8;277(10):8004-11. | ||||
REF 5 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 6 | Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol Cell Biol. 2004 Nov;24(21):9390-400. | ||||
REF 7 | EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell. 2013 Oct 14;24(4):438-49. | ||||
REF 8 | Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell. 2005 Jun;7(6):575-89. | ||||
REF 9 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 10 | Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol. 2004 Jun;6(6):547-54. | ||||
REF 11 | Blockade of glioma proliferation through allosteric inhibition of JAK2. Sci Signal. 2013 Jul 9;6(283):ra55. | ||||
REF 12 | Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):105-12. | ||||
REF 13 | Interleukin-12-induced interferon-gamma production by human peripheral blood T cells is regulated by mammalian target of rapamycin (mTOR). J Biol Chem. 2005 Jan 14;280(2):1037-43. | ||||
REF 14 | mTORC1 drives HIF-1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene. 2015 Apr 23;34(17):2239-50. | ||||
REF 15 | Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol. 2000 Jan 13;10(1):47-50. | ||||
REF 16 | Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res. 2004 Aug 15;64(16):5870-5. | ||||
REF 17 | HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene. 2005 Apr 28;24(19):3110-20. | ||||
REF 18 | ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. J Biol Chem. 2002 Oct 11;277(41):38486-93. | ||||
REF 19 | A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006 Jan 12;439(7073):168-74. | ||||
REF 20 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 21 | Constitutive activation of STAT transcription factors in acute myelogenous leukemia. Eur J Haematol. 2001 Aug;67(2):63-71. | ||||
REF 22 | Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem. 2002 Mar 1;277(9):7076-85. | ||||
REF 23 | Regulation of neutrophil adhesion by pituitary growth hormone accompanies tyrosine phosphorylation of Jak2, p125FAK, and paxillin. J Immunol. 2000 Aug 15;165(4):2116-23. | ||||
REF 24 | Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol Cell Biol. 2000 Mar;20(6):2043-54. | ||||
REF 25 | Next-generation sequencing to generate interactome datasets. Nat Methods. 2011 Jun;8(6):478-80. | ||||
REF 26 | Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells. Biochem Biophys Res Commun. 2001 Apr 27;283(1):179-87. | ||||
REF 27 | STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem. 1997 Dec 5;272(49):30607-10. | ||||
REF 28 | STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 2003 Oct 15;17(20):2564-77. | ||||
REF 29 | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. Mol Syst Biol. 2015 Jan 21;11(1):775. | ||||
REF 30 | Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin. Biochem Biophys Res Commun. 2001 Oct 19;288(1):252-7. | ||||
REF 31 | PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells. Oncogene. 2005 Nov 10;24(49):7290-300. | ||||
REF 32 | Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci U S A. 2006 May 9;103(19):7264-9. | ||||
REF 33 | STAT3 cooperates with the non-canonical NF-B signaling to regulate pro-labor genes in the human placenta. Placenta. 2015 May;36(5):581-6. | ||||
REF 34 | Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell. 2001 Feb 9;104(3):365-76. | ||||
REF 35 | HIC1 interacts with and modulates the activity of STAT3. Cell Cycle. 2013 Jul 15;12(14):2266-76. | ||||
REF 36 | Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J. 2002 Oct 1;367(Pt 1):97-105. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.